Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARRIS - Another partner -- Ignore unavailable to you. Want to Upgrade?

To: John Metcalf who wrote (224)	11/9/1997 10:15:00 PM
From: CYBERKEN	Respond to of 353

I may have started something here by accident, but I am also interested in hearing anyone's opinion on which CEO's strike them as combining business acumen and scientific capability (or, by the same token, who does not!). I think its a great risk-reducing consideration in this very risky sector.

To: John Metcalf who wrote (224)	11/10/1997 1:04:00 AM
From: chirodoc	Respond to of 353

<<<<<<At Friday's last asked quote, the arbitrage was mostly gone: ...that was my intuition about what would happen--thank you!!!! .......it is refreshing to hear someone talk about management. so often the bio threads are about the dream of the sexy new biotechnology--and the romance can quickly turn cold. <<<<<<As to outstanding CEO's, you might consider Peter Johnson of Agouron or Tim Barbarich of Sepracor. ........both stocks have had a great run and i wish i had owned them a year ago. which one do you think has the most upside left? Why?